PRO RETINA Germany invites you to the 13th International Research Colloquium on Retinal Degeneration to be held in beautiful Potsdam, Templiner See, from April 13 to 14, 2018.
From Franz Badura - President - PRO RETINA Germany
Over two days, we will address recent advances in the field of retinal diseases. Specifically, we will focus on retinal pigment epithelium and the potential of this highly functionalized monolayer as a target for treatment in retinal degenerations, including age-related macular degeneration (AMD). We will also discuss current activities in gene therapy approaches for selected monogenic retinal dystrophies and will look at the present state of knowledge in disease causes and treatment designs for both early and late stage AMD. These topics will be presented by national and international experts in the field and will provide a basis for vivid scientific exchanges.
The meeting will start with a keynote lecture presented by Prof. Dr. Hendrik Scholl, chief physician and head of the Basel University Eye Hospital. His presentation will highlightthe recent accomplishments in the field of retinal degeneration not only in basic research but most importantly in an unforeseen burst of clinical applications benefiting the visual impaired.Concluding an afternoon of science will be an evening session featuring Dr. Alexander Wilke who will critically highlight some of the issues surrounding pharmaceutical research in Germany but also worldwide.
PRO RETINA Germany, founded in 1977, is a patient organization with a longstanding commitment “to encourage ophthalmic research, to battle disease and to ensure a self-determined life of persons with retinal degeneration”. In continuation of its many activities in supporting these goals, PRO RETINA Germany has sponsored the Potsdam meeting series since its beginnings in 2005. PRO RETINA Germany also awards three poster prizes to young investigators selected from brief poster presentations. With these activities and platforms for meeting and communicating with senior and junior basic scientists as well as clinician scientist, clinicians and patients, we hope you enjoy the 2018 PRO RETINA Potsdam Symposium.
Preliminary Pro gra m
Friday, April 13, 2018
13:00 – 13:05 Welcome remarks Franz Badura
13:05 – 14:30 SESSION 1
Selected poster presentations
Eight abstracts to be selected
14:30 – 15:00 Keynote lecture
Hendrik Scholl, Basel- Cutting edge advances in the treatment of retinal degeneration
15:00 – 15:45 Coffee break
15:45 – 17:25 SESSION 2 New light on the retinal pigment epithelium (RPE)
15:45 – 16:10 Patric Turowski, London - Regulation of RPE function by ARMCproteins
16:10 – 16:35 Catherine Bowes Rickman, Durham - Ocular exosomes as diagnostic and prognostic indicators for AMD
16:35 – 17:00 Emeline F. Nandrot, Paris -Circadian phagocytosis of outer segments
by RPE cells in health and disease: More complexity than meets the eye
17:00 – 17:25 Clare E. Futter, London - Modelling lysosome dysfunction in the
retinal pigment epithelium in early AMD
19:00 – 20:00 E VENING LECTURE
Alexander Wilke, Huglfing - Pharmaceutical research yesterday, today and … ?
20:00 – open Swinging poster session
Saturday, April 14, 2018
09:00 – 10:40 SESSION 3 Gene therapy and retinal degeneration
09:00 – 09:25 Bernd Wissinger on behalf of the RD-CURE Consortium, Tübingen
- First supplementary gene therapy for CNGA3-linked Achromatopsia
09:25 – 09:50 Alun Barnard, Oxford - Development and current status of gene
therapy for choroideremia
09:50 – 10:15 Kerstin Nagel-Wolfrum, Mainz - Usher-syndrome read-through therapy
10:15 – 10:40 Antoine Chaffiol, Paris - A new promoter allows optogenetic vision
restoration with enhanced sensitivity in macaque retina
10:40 – 11:15 Coffee break
11:15 – 12:55 SESSION 4 Targeting early and late AMD
11:15 – 11:40 Iris Heid, Regensburg - Understanding the progression from early
to late AMD
11:40 – 12:05 Horst Helbig, Regensburg Treating neovascular AMD by blocking
VEGF – Experiences
Oliver Zeitz, Berlin - Treating neovascular AMD by blocking
VEGF – Prospects
12:05 – 12:30 Steffen Schmitz-Valckenberg, Bonn - Atrophic AMD – outcome measurements
12:30 – 12:55 Cedric Francois, Cambridge, USA - Targeting atrophic AMD via the complement system – Complement factor 3
12:55 – 13:00 Concluding remarks
13:00 Lunch and end of meeting
To register Log onto www.potsdam-meeting.de The registration deadline is April 09, 2018.
Cancellation is free of charge until February 25, 2018. Thereafter registration fees cannot be reimbursed.